Herman G. Berkman Diabetes Clinical Innovation Fund

Herman Gerald Berkman, PhD, believed greatly in the mission and care model of the UMass Diabetes Center of Excellence.  His estate provides ongoing support to the UMass DCOE, as result of his appreciation of our commitment to high quality and innovation. 

Dr. Berkman had an extensive teaching career as a Professor at New York University and the University of Wisconsin. He had also been a lecturer and instructor for many colleges and universities around the world, as well as a consultant to many urban renewal agencies and planning committees.

The Herman G. Berkman Chair in Diabetes Care Innovation


This endowed chair was established in 2017.   The inaugural recipient is Michael Thompson, MD, an accomplished physician-investigator, and head of the diabetes clinical research organization and outpatient clinic for the Diabetes Center of Excellence.


The Herman G. Berkman Diabetes Clinical Innovation Fund

This fund was established by UMass Memorial Health Care and our Diabetes Center of Excellence, to support the development of diabetes clinical care initiatives that would not normally find funding through medical billing operational expenses or research grant funding programs.  Special consideration is given to proposals that include:

  • Innovative approaches that directly improve the lives of people with diabetes.
  • Multidisciplinary approaches that foster inter-departmental and/or inter-institutional collaborations.
  • Support for individuals, groups, and communities that are economically or educationally disadvantaged or underrepresented.
  • Specific connection to the UMMHC core strategies of improving access, quality, patient experience, and/or growth.

Eligibility

Faculty and staff of the UMass Memorial Health Care system and the University of Massachusetts Medical School are invited to apply.   Proposal’s requesting between $50,000 and $150,000 will be considered. 

How to Apply

Email the abstract application with a copy of your curriculum vitae to: lisa.hubacz@umassmed.edu

Deadline

Abstract applications will be accepted until 5:00pm on October 31, 2018
______________________________________________________________________________________________________________________

2018 Funded Proposal Recipient

Daniel J. Amante PhD, MPH, and Adarsha S. Bajracharya, MD, were the first recipients of The Herman G. Berkman Diabetes Clinical Innovation Fund.  Their work titled, "Identifying Diabetes Patients and Linking with Underutilized Support to improve Care (ID PLUS Care)" was funded in the amount of $85,000.

Funded Project Summary
ID PLUS Care is a multidisciplinary, collaborative approach to improve care access, quality, and management for at-risk patients with diabetes. The goal of ID PLUS Care is to utilize informatics-based innovations within the Epic EHR and behavior change theory to identify vulnerable patients with gaps in their clinical care, engage them with proactive outreach support to help address their needs, and to monitor the population to provide longitudinal support.